Growth Metrics

Edwards Lifesciences (EW) Liabilities and Shareholders Equity (2009 - 2026)

Edwards Lifesciences' quarterly Liabilities and Shareholders Equity came in at $13.3 billion in Q1 2026, up 2.3% year-on-year from $13.0 billion in Q1 2025, and down 2.75% quarter-over-quarter from $13.7 billion in Q4 2025.

Edwards Lifesciences has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $13.3 billion in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 2.3% year-over-year to $13.3 billion; the trailing twelve-month figure through Mar 2026 stood at $53.8 billion (up 9.42% YoY), and the FY2025 full-year result was $13.7 billion, up 4.92% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $13.3 billion, down from $13.7 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $13.7 billion in Q4 2025, with the low at $8.3 billion in Q4 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $10.8 billion, with a median of $9.7 billion recorded in 2024.
  • Year-over-year, Liabilities and Shareholders Equity slipped 2.47% in 2022 and surged 39.43% in 2024.
  • Tracing EW's Liabilities and Shareholders Equity over 5 years: stood at $8.3 billion in 2022, then advanced by 12.91% to $9.4 billion in 2023, then surged by 39.43% to $13.1 billion in 2024, then increased by 4.92% to $13.7 billion in 2025, then fell by 2.75% to $13.3 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $13.3 billion (Q1 2026), $13.7 billion (Q4 2025), and $13.3 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 110.43 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 46.29 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 37.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 10.74 Bn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 22.72 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 13.32 Bn
Dec 31, 2025 13.70 Bn
Sep 30, 2025 13.27 Bn
Jun 30, 2025 13.49 Bn
Mar 31, 2025 13.02 Bn
Dec 31, 2024 13.06 Bn
Sep 30, 2024 12.97 Bn
Jun 30, 2024 10.10 Bn
Mar 31, 2024 9.74 Bn
Dec 31, 2023 9.36 Bn
Sep 30, 2023 9.37 Bn
Jun 30, 2023 9.00 Bn
Mar 31, 2023 8.65 Bn
Dec 31, 2022 8.29 Bn
Sep 30, 2022 8.64 Bn
Jun 30, 2022 8.43 Bn
Mar 31, 2022 8.42 Bn
Dec 31, 2021 8.50 Bn
Sep 30, 2021 8.16 Bn
Jun 30, 2021 7.66 Bn
Mar 31, 2021 7.21 Bn
Dec 31, 2020 7.24 Bn
Sep 30, 2020 6.80 Bn
Jun 30, 2020 6.42 Bn
Mar 31, 2020 6.08 Bn
Dec 31, 2019 6.49 Bn
Sep 30, 2019 5.97 Bn
Jun 30, 2019 5.57 Bn
Mar 31, 2019 5.47 Bn
Dec 31, 2018 5.32 Bn
Sep 30, 2018 5.96 Bn
Jun 30, 2018 5.69 Bn
Mar 31, 2018 5.83 Bn
Dec 31, 2017 5.67 Bn
Sep 30, 2017 5.49 Bn
Jun 30, 2017 5.14 Bn
Mar 31, 2017 4.78 Bn
Dec 31, 2016 4.51 Bn
Sep 30, 2016 4.34 Bn
Jun 30, 2016 4.05 Bn
Mar 31, 2016 3.85 Bn
Dec 31, 2015 4.06 Bn
Sep 30, 2015 3.88 Bn
Jun 30, 2015 3.61 Bn
Mar 31, 2015 3.49 Bn
Dec 31, 2014 3.52 Bn
Sep 30, 2014 3.35 Bn
Jun 30, 2014 3.33 Bn
Mar 31, 2014 2.65 Bn
Dec 31, 2013 2.71 Bn
Sep 30, 2013 2.53 Bn
Jun 30, 2013 2.34 Bn
Mar 31, 2013 2.30 Bn
Dec 31, 2012 2.22 Bn
Sep 30, 2012 2.20 Bn
Jun 30, 2012 2.08 Bn
Mar 31, 2012 2.00 Bn
Dec 31, 2011 1.98 Bn
Sep 30, 2011 1.98 Bn
Jun 30, 2011 2.00 Bn
Mar 31, 2011 1.93 Bn
Dec 31, 2010 1.77 Bn
Sep 30, 2010 1.73 Bn
Jun 30, 2010 1.64 Bn
Dec 31, 2009 1.62 Bn